3-Nitro-4-piperidin-1-ylbenzoic acid, 95.0%, 500mg

3-Bromo-N,N-dimethylpropan-1-amine hydrobromide, 95.0%, 25g

4-Bromo-1-methyl-1H-pyrazole-5-carbaldehyde, 97.0%, 5g

1-(Benzo[d]oxazol-2-yl)ethanone, 95.0%, 1g

5-Chloro-3-(3-chloro-benzyl)-[1,2,4]thiadiazole, 95.0%, 1g

3-(Dibenzylamino)oxetane-3-carbonitrile, 95.0%, 1g

ethyl 3-bromo-7-oxo-4H,7H-pyrazolo[1,5-a]pyrimidine-6-carboxylate, 95+%, 1g

5,6-DIBROMOPYRIDIN-2-AMINE, 95.0%, 10g

3-biphenyl-4-yl-1-methyl-1{H}-pyrazole-5-carboxylic acid, 95.0%, 250mg

L(+)-tartaric acid, min. 99.7%, for biochemistry, 25 kg, plastic packaging.

6-Hydroxy-2-naphthimidamide methanesulfonate salt, 95%, 5g

Pyrrolidin-1-amine hydrochloride, 90.0%, 25g

1-(But-3-en-1-yl)piperazine, 95%, 1g